FK506 Binding Protein 4, 59kDa (FKBP4) Peptide
-
- Target See all FKBP4 products
- FKBP4 (FK506 Binding Protein 4, 59kDa (FKBP4))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- ANMFERLAEE ENKAKAEASS GDHPTDTEMK EEQKSNTAGS QSQVETEA
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of FKBP4 antibody,
Alternative Names: FKBP4 control peptide, FKBP4 antibody Blocking Peptide, Anti-FKBP4 Blocking Peptide, FK506 binding protein 4, 59kDa Blocking Peptide, FKBP52 Blocking Peptide, FKBP59 Blocking Peptide, HBI Blocking Peptide, Hsp56 Blocking Peptide, PPIase Blocking Peptide, p52 Blocking Peptide, FKBP4, FKBP-4, FKBP 4, FKBP-4 Blocking Peptide, FKBP 4 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- FKBP4 (FK506 Binding Protein 4, 59kDa (FKBP4))
- Background
- This encoded protein is known to associate with phytanoyl-CoA alpha-hydroxylase. It can also associate with two heat shock proteins (hsp90 and hsp70) and thus may play a role in the intracellular trafficking of hetero-oligomeric forms of the steroid hormone receptors. This protein correlates strongly with adeno-associated virus type 2 vectors (AAV) resulting in a significant increase in AAV-mediated transgene expression in human cell lines. Thus this encoded protein is thought to have important implications for the optimal use of AAV vectors in human gene therapy.
- Molecular Weight
- 52 kDa
-